(Q40207574)

English

Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction

scientific article published on July 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 September 2017

Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction (English)

1 reference

Europe PubMed Central

18 September 2017

author name string

Melanoma Study Group of the Mayo Clinic Cancer Center

1

1 reference

Europe PubMed Central

18 September 2017

Esteban Celis

2

1 reference

Europe PubMed Central

18 September 2017

language of work or name

0 references

publication date

1 July 2007

1 reference

Europe PubMed Central

18 September 2017

1 reference

Europe PubMed Central

18 September 2017

110

1 reference

Europe PubMed Central

18 September 2017

1

1 reference

Europe PubMed Central

18 September 2017

203-214

1 reference

Europe PubMed Central

18 September 2017

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

21 January 2018

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

21 January 2018

Dendritic cell defects in patients with cancer: mechanisms and significance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Quiescent phenotype of tumor-specific CD8+ T cells following immunization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2: clinical applications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Principles and use of anti-CTLA4 antibody in human cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

A reproducible method for the enumeration of functional (cytokine producing) versus non-functional peptide-specific cytotoxic T lymphocytes in human peripheral blood

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Peptide-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunosuppression in melanoma immunotherapy: potential opportunities for intervention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms and functional significance of tumour-induced dendritic-cell defects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of immature myeloid cells in mechanisms of immune evasion in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic potential of cytokine and chemokine antagonists in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Mini-transplantation strategy for solid tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22744

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22744

1 reference

Europe PubMed Central

18 September 2017

1 reference

Europe PubMed Central

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40207574&oldid=1888726570"